Session 147 - 12th CROI

Home

Session 147 Poster Abstracts
Clinical Studies of Hyperlipidemia, Fat Redistribution, and Glucose Metabolism
Thursday, 1:30 - 3:30 pm
Hall B

843	Protease Inhibitors, Apolipoprotein C-III Polymorphisms and Atherogenic Dyslipidemia in HIV A Foulkes¹, D Wohl², P Tebas³, I Frank³, M Dube⁴, E Puleo¹, M Wolfe¹, S Restine¹, R Parker⁵, D Rader³, and Muredach Reilly*³ ¹Univ of Massachusetts, Amherst, USA; ²Univ of North Carolina at Chapel Hill, USA; ³Univ of Pennsylvania, Philadelphia, USA; ⁴Indiana Univ, Indianapolis, USA; and ⁵Harvard Univ, Boston, MA, USA
844	MRI Measurement of the Volume and Anatomical Distribution of Facial Fat Depletion in Lipodystrophy and Wasting Nicholas Paton*¹, Y Yang¹, Y Sitoh², and O Naing¹ ¹Tan Tock Seng Hosp, Singapore and ²Natl NeuroSci Inst, Singapore
845	Low Levels of Lipin mRNA Expression in Adipose Tissues from HIV-infected Patients with Lipodystrophy Birgitte Lindegaard*¹, L Frydelund-Larsen¹, A B Hansen¹, J Gerstoft¹, B Pedersen¹, and K Reue² ¹Rigshospitalet, Copenhagen, Denmark and ²Geffen Sch of Med, Univ of California, Los Angeles, USA
846	Lipid and Lipoprotein Changes during Short-term Protease Inhibitor and Efavirenz Exposure in HIV-seronegative Subjects Susan Rosenkranz*¹, K Yarasheski², M Para³, R Reichman⁴, G Morse⁵, and the ACTG A5043 Team ¹Harvard Sch of Publ Hlth, Boston, MA, USA; ²Washington Univ, St Louis, MO, USA; ³Ohio State Univ, Columbus, USA; ⁴Univ of Rochester, NY, USA; and ⁵State Univ of New York at Buffalo, USA
847	Dyslipidaemia in an Asian Population following Treatment for 2 Years with 5 Different Protease Inhibitor-containing Regimens: The HIV-NAT Cohort Chris Duncombe*¹, S Kerr¹, A Avihingsanon¹, M Boyd¹, B Sopa¹, D Cooper², J Lange³, P Phanuphak¹, K Ruxrungtham¹, and HIV-NAT Study Group ¹The HIV Netherlands, Australia, Thailand Res Collaboration, Bangkok; ²Natl Ctr in HIV Epidemiology and Clin Res, Univ of New South Wales, Sydney, Australia; and ³Intl Antiviral Therapy Evaluation Ctr, Amsterdam, The Netherlands
848	Demographic and Clinical Characteristics of HIV+ Men and Women in the Study of Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) Are Comparable to a National Probability Sample of HIV+ Patients in Medical Care in the U.S. Phyllis Tien*^1,2, C Benson³, A Zolopa⁵, C Grunfeld^1,2, D Osmond⁴, and for the FRAM Study ¹Univ of California, San Francisco, USA; ²San Francisco VA Med Ctr, CA, USA; ³Univ of Colorado, Denver, USA; ⁴Univ of California, San Francisco, USA; and ⁵Stanford Univ, CA, USA
849	ART and the Longitudinal Assessment of Anthropometrics in the Multicenter AIDS Cohort Study Todd Brown*¹, Z Wang¹, H Chu¹, F Palella², L Kingsley³, M Witt⁴, and A Dobs¹ ¹Johns Hopkins Univ, Baltimore, MD, USA; ²Northwestern Univ, Chicago, IL, USA; ³Univ of Pittsburgh, PA, USA; and ⁴Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, USA
850	Effects of Switching to Ritonavir-boosted Atazanavir on HIV-infected Patients Receiving Antiretroviral Therapy with Hyperlipidemia. E Martinez*¹, C Azuaje², A Antela³, A Rivero⁴, F Lozano⁵, E Deig⁶, D Fuster⁷, O Serrano⁸, and BMS study 900 ATV Early Access Program-Spain ¹Hosp Clin, Barcelona, Spain; ²Hosp Vall d'Hebron, Barcelona, Spain; ³Hosp Ramon y Cajal, Madrid, Spain; ⁴Hosp Reina Sofia, Cordoba, Spain; ⁵Hospital de Valme, Sevilla, Spain; ⁶Hosp de Granollers, Barcelona, Spain; ⁷Hosp Germans Trias i Pujol, Barcelona, Spain; and ⁸Bristol-Myers Squibb, Madrid, Spain
851	Subcutaneous Polylactic Acid in HIV-1-associated Facial Lipoatrophy: Clinical and Spiral CTScan Outcome as Predictors of Response Anne Mijch*, C Bowtell-Harris, B Archer, and J Hoy Alfred Hosp, Melbourne, Australia
852	Influence of Host and Disease Factors on ART-associated Co-morbidity Kenneth Lichtenstein*¹, C Armon², K Wood², A Moorman³, and S Holmberg³ ¹Univ of Colorado Hlth Sci Ctr, Denver, USA; ²Cerner Corp, Vienna, VA, USA; and ³CDC, Atlanta, GA, USA
853	Disorders of Glucose Metabolism and Insulin Resistance in HIV-infected Patients Treated with Protease Inhibitors. Considerations on Frequency and Clinical Management, in a Prospective Randomized Study L Calza, Roberto Manfredi*, and F Chiodo Univ of Bologna, Italy